The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
D | Dermatologicals | |
2
|
D04 | Antipruritics, incl. antihistamines, anesthetics, etc. | |
3
|
D04A | Antipruritics, incl. antihistamines, anesthetics, etc. | |
4
|
D04AB | Anesthetics for topical use | |
5
|
D04AB01 | Lidocaine |
| Active Ingredient |
|---|
|
Lidocaine, like other local anaesthetics, causes a reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the nerve membrane. Local anaesthetics of the amide-type are thought to act within the sodium channels of the nerve membrane. |
| Document | Type | Information Source | |
|---|---|---|---|
| LMX4 Cream | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| STUD 100 | MPI, EU: SmPC | Marketing Authorisation Holder |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.